222 related articles for article (PubMed ID: 25409201)
41. Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis.
Pilling D; Zheng Z; Vakil V; Gomer RH
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18291-6. PubMed ID: 25489114
[TBL] [Abstract][Full Text] [Related]
42. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.
Moua T; Zamora Martinez AC; Baqir M; Vassallo R; Limper AH; Ryu JH
Respir Res; 2014 Dec; 15(1):154. PubMed ID: 25472884
[TBL] [Abstract][Full Text] [Related]
43. Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis.
Huang WT; Akhter H; Jiang C; MacEwen M; Ding Q; Antony V; Thannickal VJ; Liu RM
Exp Gerontol; 2015 Jan; 61():62-75. PubMed ID: 25451236
[TBL] [Abstract][Full Text] [Related]
44. Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis.
Chung KP; Hsu CL; Fan LC; Huang Z; Bhatia D; Chen YJ; Hisata S; Cho SJ; Nakahira K; Imamura M; Choi ME; Yu CJ; Cloonan SM; Choi AMK
Nat Commun; 2019 Jul; 10(1):3390. PubMed ID: 31358769
[TBL] [Abstract][Full Text] [Related]
45. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.
Tsubouchi K; Araya J; Yoshida M; Sakamoto T; Koumura T; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Hashimoto M; Wakui H; Numata T; Kaneko Y; Mori S; Asano H; Matsudaira H; Ohtsuka T; Nakayama K; Nakanishi Y; Imai H; Kuwano K
J Immunol; 2019 Oct; 203(8):2076-2087. PubMed ID: 31534007
[TBL] [Abstract][Full Text] [Related]
46. Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways.
Suryadevara V; Ramchandran R; Kamp DW; Natarajan V
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549377
[TBL] [Abstract][Full Text] [Related]
47. Alveolar lipids in pulmonary disease. A review.
Agudelo CW; Samaha G; Garcia-Arcos I
Lipids Health Dis; 2020 Jun; 19(1):122. PubMed ID: 32493486
[TBL] [Abstract][Full Text] [Related]
48. Resident interstitial lung fibroblasts and their role in alveolar stem cell niche development, homeostasis, injury, and regeneration.
Ushakumary MG; Riccetti M; Perl AT
Stem Cells Transl Med; 2021 Jul; 10(7):1021-1032. PubMed ID: 33624948
[TBL] [Abstract][Full Text] [Related]
49. Role of macrophage TRPV4 in inflammation.
Dutta B; Arya RK; Goswami R; Alharbi MO; Sharma S; Rahaman SO
Lab Invest; 2020 Feb; 100(2):178-185. PubMed ID: 31645630
[TBL] [Abstract][Full Text] [Related]
50. Metabolic Reprogramming as a Driver of Fibroblast Activation in PulmonaryFibrosis.
Para R; Romero F; George G; Summer R
Am J Med Sci; 2019 May; 357(5):394-398. PubMed ID: 30879738
[TBL] [Abstract][Full Text] [Related]
51. A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.
Fessler MB
Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S399-S405. PubMed ID: 29161079
[TBL] [Abstract][Full Text] [Related]
52. Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study.
Zhao YD; Yin L; Archer S; Lu C; Zhao G; Yao Y; Wu L; Hsin M; Waddell TK; Keshavjee S; Granton J; de Perrot M
BMJ Open Respir Res; 2017; 4(1):e000183. PubMed ID: 28883924
[TBL] [Abstract][Full Text] [Related]
53. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.
Xu Y; Mizuno T; Sridharan A; Du Y; Guo M; Tang J; Wikenheiser-Brokamp KA; Perl AT; Funari VA; Gokey JJ; Stripp BR; Whitsett JA
JCI Insight; 2016 Dec; 1(20):e90558. PubMed ID: 27942595
[TBL] [Abstract][Full Text] [Related]
54. Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis.
Kang YP; Lee SB; Lee JM; Kim HM; Hong JY; Lee WJ; Choi CW; Shin HK; Kim DJ; Koh ES; Park CS; Kwon SW; Park SW
J Proteome Res; 2016 May; 15(5):1717-24. PubMed ID: 27052453
[TBL] [Abstract][Full Text] [Related]
55. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
Xie N; Tan Z; Banerjee S; Cui H; Ge J; Liu RM; Bernard K; Thannickal VJ; Liu G
Am J Respir Crit Care Med; 2015 Dec; 192(12):1462-74. PubMed ID: 26284610
[TBL] [Abstract][Full Text] [Related]
56. Cellular and Molecular Control of Lipid Metabolism in Idiopathic Pulmonary Fibrosis: Clinical Application of the Lysophosphatidic Acid Pathway.
Nakamura Y; Shimizu Y
Cells; 2023 Feb; 12(4):. PubMed ID: 36831215
[TBL] [Abstract][Full Text] [Related]
57. Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis.
Burgy O; Loriod S; Beltramo G; Bonniaud P
Cells; 2022 Apr; 11(7):. PubMed ID: 35406772
[TBL] [Abstract][Full Text] [Related]
58. Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids.
Roque W; Romero F
Am J Physiol Cell Physiol; 2021 May; 320(5):C689-C695. PubMed ID: 33471621
[TBL] [Abstract][Full Text] [Related]
59. Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis.
Kim HS; Yoo HJ; Lee KM; Song HE; Kim SJ; Lee JO; Hwang JJ; Song JW
Respirology; 2021 Mar; 26(3):255-263. PubMed ID: 33025706
[TBL] [Abstract][Full Text] [Related]
60. Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.
Ballester B; Milara J; Cortijo J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
